Free Trial

PDT Partners LLC Makes New $588,000 Investment in The Pennant Group, Inc. (NASDAQ:PNTG)

The Pennant Group logo with Medical background

PDT Partners LLC acquired a new stake in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,474 shares of the company's stock, valued at approximately $588,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. FMR LLC increased its stake in shares of The Pennant Group by 51.3% in the 3rd quarter. FMR LLC now owns 2,528,512 shares of the company's stock worth $90,268,000 after purchasing an additional 856,838 shares in the last quarter. Vanguard Group Inc. increased its position in The Pennant Group by 4.3% in the first quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company's stock worth $36,505,000 after buying an additional 77,052 shares in the last quarter. Crewe Advisors LLC raised its stake in shares of The Pennant Group by 1.6% in the third quarter. Crewe Advisors LLC now owns 742,958 shares of the company's stock worth $26,524,000 after buying an additional 11,927 shares during the period. First Eagle Investment Management LLC lifted its position in shares of The Pennant Group by 2.1% during the 2nd quarter. First Eagle Investment Management LLC now owns 391,748 shares of the company's stock valued at $9,085,000 after buying an additional 8,000 shares in the last quarter. Finally, De Lisle Partners LLP grew its stake in shares of The Pennant Group by 7.6% during the 3rd quarter. De Lisle Partners LLP now owns 343,340 shares of the company's stock valued at $12,254,000 after acquiring an additional 24,321 shares during the period. Institutional investors own 85.88% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on PNTG shares. Truist Financial raised their price target on The Pennant Group from $34.00 to $38.00 and gave the company a "hold" rating in a report on Monday, October 7th. Stephens reissued an "overweight" rating and set a $40.00 target price on shares of The Pennant Group in a research note on Wednesday, October 9th. Royal Bank of Canada upped their price target on The Pennant Group from $26.00 to $38.00 and gave the stock an "outperform" rating in a research note on Wednesday, October 23rd. Finally, Oppenheimer lifted their price objective on shares of The Pennant Group from $34.00 to $37.00 and gave the company an "outperform" rating in a research report on Friday, November 8th.

View Our Latest Report on The Pennant Group

The Pennant Group Trading Down 1.8 %

PNTG traded down $0.57 on Tuesday, reaching $30.99. 128,903 shares of the company traded hands, compared to its average volume of 200,685. The company has a market cap of $1.06 billion, a P/E ratio of 45.57, a price-to-earnings-growth ratio of 3.22 and a beta of 1.95. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The Pennant Group, Inc. has a one year low of $13.24 and a one year high of $37.13. The firm has a fifty day simple moving average of $32.96 and a two-hundred day simple moving average of $29.74.

The Pennant Group Company Profile

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Further Reading

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should you invest $1,000 in The Pennant Group right now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Former Trump Advisor: Expect REITs to Soar Under Trump’s Next Presidency
Super Micro’s Rebound: Can SMCI Stock Rally Another 100%?
Why Meta Is Still a Top Stock Pick for 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines